AMAG Pharmaceuticals: 3Q Earnings Snapshot
WALTHAM, Mass. (AP) _ AMAG Pharmaceuticals Inc. (AMAG) on Thursday reported third-quarter net income of $30.8 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Waltham, Massachusetts-based company said it had profit of 89 cents. Losses, adjusted for one-time gains and costs, were 77 cents per share.
The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 77 cents per share.
The specialty drugmaker posted revenue of $122.2 million in the period, surpassing Street forecasts. Six analysts surveyed by Zacks expected $117.7 million.
AMAG Pharmaceuticals expects full-year revenue in the range of $470 million to $490 million.
AMAG Pharmaceuticals shares have climbed 64 percent since the beginning of the year. The stock has increased 38 percent in the last 12 months.